231 related articles for article (PubMed ID: 18415952)
21. The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone.
Udelson JE; Pearte CA; Kimmelstiel CD; Kruk M; Kufera JA; Forman SA; Teresinska A; Bychowiec B; Marin-Neto JA; Höchtl T; Cohen EA; Caramori P; Busz-Papiez B; Adlbrecht C; Sadowski ZP; Ruzyllo W; Kinan DJ; Lamas GA; Hochman JS
Am Heart J; 2011 Mar; 161(3):611-21. PubMed ID: 21392619
[TBL] [Abstract][Full Text] [Related]
22. Effects of a timely therapy with doxycycline on the left ventricular remodeling according to the pre-procedural TIMI flow grade in patients with ST-elevation acute myocardial infarction.
Cerisano G; Buonamici P; Valenti R; Moschi G; Taddeucci E; Giurlani L; Migliorini A; Vergara R; Parodi G; Sciagrà R; Romito R; Colonna P; Antoniucci D
Basic Res Cardiol; 2014 Jul; 109(4):412. PubMed ID: 24825768
[TBL] [Abstract][Full Text] [Related]
23. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators.
Lamas GA; Flaker GC; Mitchell G; Smith SC; Gersh BJ; Wun CC; Moyé L; Rouleau JL; Rutherford JD; Pfeffer MA
Circulation; 1995 Sep; 92(5):1101-9. PubMed ID: 7648653
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study.
Taniguchi N; Nakamura T; Sawada T; Matsubara K; Furukawa K; Hadase M; Nakahara Y; Nakamura T; Matsubara H
Circ J; 2010 Nov; 74(11):2365-71. PubMed ID: 20834185
[TBL] [Abstract][Full Text] [Related]
25. Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction.
Horiuchi Y; Tanimoto S; Aoki J; Nakajima H; Hara K; Tanabe K
Int J Cardiol; 2016 Oct; 221():765-9. PubMed ID: 27428318
[TBL] [Abstract][Full Text] [Related]
26. Comparison of usefulness of left ventricular diastolic versus systolic function as a predictor of outcome following primary percutaneous coronary angioplasty for acute myocardial infarction.
Naqvi TZ; Padmanabhan S; Rafii F; Hyuhn HK; Mirocha J
Am J Cardiol; 2006 Jan; 97(2):160-6. PubMed ID: 16442355
[TBL] [Abstract][Full Text] [Related]
27. Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP).
Rashba EJ; Lamas GA; Couderc JP; Hollist SM; Dzavik V; Ruzyllo W; Fridrich V; Buller CE; Forman SA; Kufera JA; Carvalho AC; Hochman JS;
Circulation; 2009 Feb; 119(6):779-87. PubMed ID: 19188505
[TBL] [Abstract][Full Text] [Related]
28. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.
Lipinski MJ; Biondi-Zoccai GG; Abbate A; Khianey R; Sheiban I; Bartunek J; Vanderheyden M; Kim HS; Kang HJ; Strauer BE; Vetrovec GW
J Am Coll Cardiol; 2007 Oct; 50(18):1761-7. PubMed ID: 17964040
[TBL] [Abstract][Full Text] [Related]
29. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Ørn S; Ueland T; Manhenke C; Sandanger Ø; Godang K; Yndestad A; Mollnes TE; Dickstein K; Aukrust P
J Intern Med; 2012 Sep; 272(3):267-76. PubMed ID: 22243053
[TBL] [Abstract][Full Text] [Related]
30. Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy.
Bahrmann P; Rach J; Desch S; Schuler GC; Thiele H
Clin Res Cardiol; 2011 May; 100(5):457-67. PubMed ID: 21165625
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous versus surgical revascularization for multivessel coronary artery disease: a single center 10 year follow-up of SOS trial patients.
Buszman P; Wiernek S; Szymanski R; Bialkowska B; Buszman P; Fil W; Stables R; Bochenek A; Martin J; Tendera M
Catheter Cardiovasc Interv; 2009 Sep; 74(3):420-6. PubMed ID: 19360866
[TBL] [Abstract][Full Text] [Related]
32. Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials.
Xu JY; Liu D; Zhong Y; Huang RC
Stem Cell Res Ther; 2017 Oct; 8(1):231. PubMed ID: 29037256
[TBL] [Abstract][Full Text] [Related]
33. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.
Delewi R; Hirsch A; Tijssen JG; Schächinger V; Wojakowski W; Roncalli J; Aakhus S; Erbs S; Assmus B; Tendera M; Goekmen Turan R; Corti R; Henry T; Lemarchand P; Lunde K; Cao F; Huikuri HV; Sürder D; Simari RD; Janssens S; Wollert KC; Plewka M; Grajek S; Traverse JH; Zijlstra F; Piek JJ
Eur Heart J; 2014 Apr; 35(15):989-98. PubMed ID: 24026778
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome.
Hoebers LP; Claessen BE; Elias J; Dangas GD; Mehran R; Henriques JP
Int J Cardiol; 2015; 187():90-6. PubMed ID: 25828320
[TBL] [Abstract][Full Text] [Related]
35. Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Non-Infarct-Related Arteries in Patients With Acute Myocardial Infarction (from the COREA-AMI Registry).
Choi IJ; Koh YS; Lim S; Choo EH; Kim JJ; Hwang BH; Kim TH; Seo SM; Kim CJ; Park MW; Shin DI; Choi YS; Park HJ; Her SH; Kim DB; Park CS; Lee JM; Moon KW; Chang K; Kim HY; Yoo KD; Jeon DS; Chung WS; Ahn Y; Jeong MH; Seung KB; Kim PJ
Am J Cardiol; 2016 Apr; 117(7):1039-46. PubMed ID: 26993974
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.
Buller CE; Rankin JM; Carere RG; Buszman PE; Pfisterer ME; Dzavik V; Thomas B; Forman S; Ruzyllo W; Mancini GB; Michalis LK; Abreu PF; Lamas GA; Hochman JS
Am Heart J; 2009 Sep; 158(3):408-15. PubMed ID: 19699864
[TBL] [Abstract][Full Text] [Related]
37. Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function.
Bollati M; Gerasimou A; Sillano D; Biondi-Zoccai G; Garrone P; Moretti C; Sciuto F; Omedé P; Trevi GP; Sheiban I
Catheter Cardiovasc Interv; 2010 Mar; 75(4):586-93. PubMed ID: 20088012
[TBL] [Abstract][Full Text] [Related]
38. Infarct zone viability influences ventricular remodelling after late recanalisation of an occluded infarct related artery.
Bellenger NG; Yousef Z; Rajappan K; Marber MS; Pennell DJ
Heart; 2005 Apr; 91(4):478-83. PubMed ID: 15772205
[TBL] [Abstract][Full Text] [Related]
39. Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study Group.
Meneveau N; Bassand JP; Bauters C; Rozand JY; Petit JL; Beurrier D; Grollier G; Andre F; Vahanian A; Viel JF
Eur Heart J; 1997 Aug; 18(8):1261-8. PubMed ID: 9458418
[TBL] [Abstract][Full Text] [Related]
40. Long-term clinical outcomes of successful versus unsuccessful revascularization with drug-eluting stents for true chronic total occlusion.
Lee SW; Lee JY; Park DW; Kim YH; Yun SC; Kim WJ; Suh J; Cho YH; Lee NH; Kang SJ; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2011 Sep; 78(3):346-53. PubMed ID: 21452248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
